John Pavlidis, MS
CEO, EosDx Inc.
John Pavlidis has over 35 years in Healthcare Technologies. He started his career at Siemens Healthcare where he was the Vice President of MRI in the US and then became the global CEO of Ultrasound in 2000. He left Siemens in 2004 and subsequently joined R2 Technology as the startup's CEO. The company was acquired by Hologic in 2006. John then became the CEO of Endoscopic Technologies a company with a variety of products in the minimally invasive cardiac surgery space. Endoscopic Technologies was acquired by Atricure in 2013. Prior to EosDx, John was the CEO of Vytronus Inc. an innovative robotic catheter company for the endocardial treatment of atrial fibrillation. John has also served on several HealthTech company boards, including U-systems Inc. acquired by GE and Clario Medical acquired by Intelerad.